share_log

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shlevin Harold H.

SEC ·  Dec 31, 2024 20:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more